Cardiovascular risk assessment for osteoporosis patients considering Romosozumab
Clark, Emma Walsh, Katherine Bailey, Sarah-Jane Roy, Matthew Hardcastle, Sarah Cockill, Clare Tobias, Jon Faber, Ben
Clark, Emma
Walsh, Katherine
Bailey, Sarah-Jane
Roy, Matthew
Hardcastle, Sarah
Cockill, Clare
Tobias, Jon
Faber, Ben
Glos Author
Date
2024-10-23
Journal Title
Subject
Type
Journal Article
Collections
Abstract
Cardiovascular risk scoaring tools are suitable for but not interchangable within the osteoporosis clinic.
Citation
Macrae, F., Clark, E. M., Walsh, K., Bailey, S. J., Roy, M., Hardcastle, S., Cockill, C., Tobias, J. H., & Faber, B. G. (2025). Cardiovascular risk assessment for osteoporosis patients considering Romosozumab. Bone, 190, 117305. https://doi.org/10.1016/j.bone.2024.117305